Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Moore

Showing results (131-140 of 162) with videos related to

Pageof 17
Sort By:
Neuroreport|February 15, 1995
Angiotensinogen-like epitopes are present in the CNS of Aplysia california and co-localize with urotensin I- and urotensin II-like immunoreactivities in the cerebral gangliaG C Gonzalez, I Roger, E Gonzalez, et al.
Biological Psychiatry|February 22, 2000
Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorderK D Fitzgerald, G J Moore, L A Paulson, et al.
Proceedings of the Western Pharmacology Society|January 1, 1984
On the mechanisms of action of two classes of angiotensin antagonists at smooth muscle receptorsG J Moore, J M Matsoukas, M N Scanlon, et al.
International Journal of Peptide and Protein Research|January 1, 1991
Synthesis and biological activities of angiotensin II and Sarmesin analogues containing cyclohexylalanineJ Hondrelis, J Matsoukas, P Cordopatis, et al.
Journal of Medicinal Chemistry|June 1, 1985
Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophanJ M Matsoukas, M H Goghari, M N Scanlon, et al.
Psychosomatic Medicine|October 8, 1999
Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressantsG Chen, K A Hasanat, J M Bebchuk, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 1999
The optimal dose of radiation in Hodgkin's disease: an analysis of clinical and treatment factors affecting in-field disease controlN P Mendenhall, L L Rodrigue, G J Moore-Higgs, et al.
The Journal of Clinical Psychiatry|March 12, 1999
Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implicationsH K Manji, J M Bebchuk, G J Moore, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2000
Structural comparison between type I and type II antagonists: possible implications in the drug design of AT1 antagonistsP Roumelioti, T Tselios, K Alexopoulos, et al.
Amino Acids|January 1, 1999
Design and synthesis of small semi-mimetic peptides with immunomodulatory activity based on myelin basic protein (MBP)T Tselios, L Probert, G Kollias, et al.
Pageof 17

Showing results (131-140 of 162) with videos related to

Sort By:
Pageof 17
Neuroreport|February 15, 1995
Angiotensinogen-like epitopes are present in the CNS of Aplysia california and co-localize with urotensin I- and urotensin II-like immunoreactivities in the cerebral gangliaG C Gonzalez, I Roger, E Gonzalez, et al.
Biological Psychiatry|February 22, 2000
Proton spectroscopic imaging of the thalamus in treatment-naive pediatric obsessive-compulsive disorderK D Fitzgerald, G J Moore, L A Paulson, et al.
Proceedings of the Western Pharmacology Society|January 1, 1984
On the mechanisms of action of two classes of angiotensin antagonists at smooth muscle receptorsG J Moore, J M Matsoukas, M N Scanlon, et al.
International Journal of Peptide and Protein Research|January 1, 1991
Synthesis and biological activities of angiotensin II and Sarmesin analogues containing cyclohexylalanineJ Hondrelis, J Matsoukas, P Cordopatis, et al.
Journal of Medicinal Chemistry|June 1, 1985
Synthesis and biological activities of analogues of angiotensins II and III containing O-methyltyrosine and D-tryptophanJ M Matsoukas, M H Goghari, M N Scanlon, et al.
Psychosomatic Medicine|October 8, 1999
Regulation of signal transduction pathways and gene expression by mood stabilizers and antidepressantsG Chen, K A Hasanat, J M Bebchuk, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 1999
The optimal dose of radiation in Hodgkin's disease: an analysis of clinical and treatment factors affecting in-field disease controlN P Mendenhall, L L Rodrigue, G J Moore-Higgs, et al.
The Journal of Clinical Psychiatry|March 12, 1999
Modulation of CNS signal transduction pathways and gene expression by mood-stabilizing agents: therapeutic implicationsH K Manji, J M Bebchuk, G J Moore, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2000
Structural comparison between type I and type II antagonists: possible implications in the drug design of AT1 antagonistsP Roumelioti, T Tselios, K Alexopoulos, et al.
Amino Acids|January 1, 1999
Design and synthesis of small semi-mimetic peptides with immunomodulatory activity based on myelin basic protein (MBP)T Tselios, L Probert, G Kollias, et al.
Pageof 17